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ABSTRACT
A 15-mer DNA aptamer (named TBA) adopts a
G-quadruplex structure that strongly inhibits
fibrin-clot formation by binding to thrombin. We
have performed thermodynamic analysis, binding
affinity and biological activity studies of TBA
variants modified by unlocked nucleic acid
(UNA) monomers. UNA-U placed in position U3,
U7 or U12 increases the thermodynamic
stability of TBA by 0.15–0.50kcal/mol. In contrast,
modification of any position within the two
G-quartet structural elements is unfavorable for
quadruplex formation. The intramolecular
folding of the quadruplexes is confirmed by Tm
versus ln c analysis. Moreover, circular dichroism
and thermal difference spectra of the modified
TBAs displaying high thermodynamic stability
show bands that are characteristic for antiparallel
quadruplex formation. Surface plasmon resonance
studies of the binding of the UNA-modified
TBAs to thrombin show that a UNA monomer is
allowed in many positions of the aptamer without
significantly changing the thrombin-binding
properties. The biological effect of a selection of
the modified aptamers was tested by a thrombin
time assay and showed that most of the UNA-
modified TBAs possess anticoagulant properties,
and that the construct with a UNA-U monomer in
position 7 is a highly potent inhibitor of fibrin-clot
formation.
INTRODUCTION
G-quadruplexes constitute a unique class of highly-
ordered nucleic acids structures with various folding
topologies and molecularities. They are present in natur-
ally occurring nucleic acids and play important regulatory
functions in many biological processes (1–6). The occur-
rence of quadruplex structures in genomes of diverse
organisms suggested the possibility to design potential
drug components targeted towards G-quadruplexes or
based on RNA or DNA G-quartets (7–15).
The 15-mer DNA oligonucleotide 50-GGTTGGTGTG
GTTGG is a thrombin binding aptamer (16). The
aptamer, hereafter named TBA, was discovered in 1992
by in vitro selection and found to inhibit ﬁbrin-clot forma-
tion by binding to the thrombin protein with high select-
ivity and afﬁnity. According to NMR and X-ray
structural studies TBA forms an intramolecular, antipar-
allel G-quadruplex with a chair-like conformation (17,18).
The core of the quadruplex consists of two G-quartets
connected by three edge-wise loops: a central TGT loop
and two TT loops (Figure 1a). The aptamer interacts with
two thrombin molecules, inactivating only one of them
(18–20). X-ray studies indicated that inhibition of
ﬁbrinogen-clotting is a result of speciﬁc blocking of the
thrombin anion exosite I by an interaction involving the
central TGT loop (Figure 1b) (18–20). In the same studies
it was furthermore reported that the two TT loops are
involved in ionic interactions with the electropositive
heparin binding site of a second thrombin molecule in
the crystals to compensate the residual negative charge
of the aptamer. In contrast, NMR studies indicated that
the two TT loops interact with the thrombin anion
exosite I (Figure 1c), while the TGT loop is in close
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thrombin molecule (18,20).
It has been suggested that the stability and rigidity of
TBA is essential for interaction with the thrombin anion
exosite I (21), and attempts to improve biological activity
and thermal stability via chemical and structural modiﬁ-
cations have been performed. Modiﬁcations have included
4-thio-20-deoxyuridine (22), LNA (locked nucleic acid)
(23,24), 20-deoxy-isoguanosine (25), RNA (26,27) or
20-O-methyl-RNA nucleotides (26,28), methylphosphonate
or phosphorothioate internucleoside linkages (26,28),
partial inversion of TBA polarity (50-30!30-50) with an
50-50 internucleoside linkage (29,30), or changes of loop
size and sequence (31). Most of these modiﬁed TBAs
have displayed retained or decreased thermal stability
relative to the reference unmodiﬁed TBA. However
variants containing e.g. 4-thio-20-deoxyuridine or
20-deoxy-isoguanosine nucleotides or phosphorothioate
linkages have shown improved anticoagulant properties.
The chemical synthesis and thermal analysis of the
UNA (unlocked nucleic acid) thymine monomer was
ﬁrst described by us in 1995 when a UNA monomer was
shown to decrease the thermal stability (Tm value) of
DNA duplexes (32). UNA is an acyclic RNA mimic
(Figure 2) and in many ways the polar opposite to LNA
(locked nucleic acid) within nucleic acid analogs. The
missing bond between the C20 and C30 atoms of the
ribose ring makes a UNA monomer more ﬂexible than
an unmodiﬁed RNA monomer. The synthesis of
UNA-A, -C, -G and -U phosphoramidites, introduction
of all UNA monomers into RNA and DNA duplexes,
and thermal denaturation studies have recently been
described (33,34). It was reported that UNA monomers,
depending on their position in a duplex, either increase or
decrease mismatch discrimination against DNA/RNA
target strands, while they in a predictive and additive
manner decrease the thermodynamic stability of
duplexes (33–35). Moreover, a number of interesting bio-
logical applications of UNA-modiﬁed oligonucleotides,
e.g. UNA-modiﬁed siRNAs, have recently been docu-
mented (36–39).
Herein we examine the inﬂuence of UNA on thermo-
dynamic stability, binding afﬁnity and biological activity
of the quadruplex forming TBA. The modiﬁed variants
are aptamers singly substituted with a UNA monomer
in every possible position (Table 1). UV melting analysis
was applied for comprehensive thermodynamic studies
providing information about stoichiometry of the
folding process as well as detailed thermodynamic param-
eters for the ﬁfteen UNA-modiﬁed TBA variants. Thermal
difference and circular dichroism (CD) spectra allowed
determination of the effect of UNA substitutions on the
structure of the TBA variants. Furthermore, surface
plasmon resonance was used to investigate the afﬁnity of
the UNA-modiﬁed TBA analogs to thrombin. Finally,
blood clotting studies with a selection of UNA-modiﬁed
TBAs were performed to test their anticoagulant
properties.
MATERIALS AND METHODS
Oligonucleotides
The 50-biotinylated UNA oligonucleotides were
synthesized on an automated RNA/DNA synthesizer
(UNA phosphoramidite monomers and UNA-modiﬁed
oligonucleotides are commercially available from www.
ribotask.dk) using standard phosphoramidite chemistry.
The [1-N-(4,40-dimethoxytrityl)biotinyl-6-aminohexyl]-
2-cyanoethyl(N,N-diisopropyl)phosphoramidite was
applied to 50-biotinylation of oligonucleotides. The
O30-phosphoramidites of UNA nucleotides were applied
according to the previously described procedures (33)
together with commercial DNA phosphoramidites.
The purity of all oligonucleotides was veriﬁed by
ion-exchange HPLC and determined to be 80% or
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Figure 1. Quadruplex structure of the thrombin binding aptamer (TBA) (a), and its interaction with the thrombin anion exosite I according to X-ray
(b) and NMR (c) studies (20). Thrombin is marked in gray, TBA is marked in red (dG) and blue (T).
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Figure 2. Structure of a UNA nucleotide monomer.
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conﬁrmed by MALDI–TOF mass spectrometry.
UV melting analysis of TBA variants
Oligonucleotides were dissolved in a buffer containing
100mM potassium chloride and 10mM sodium cacody-
late, pH 7.0. Oligonucleotide single strand concentrations
were calculated from the absorbance measured above 80 C
(40) and extinction coefﬁcients which were approximated
by a nearest-neighbor model (40,41) with the HyTher
program. UNA-modiﬁed and unmodiﬁed DNA strands
with identical sequences were assumed to have identical
extinction coefﬁcients. The samples were renatured by
5min at 80 C and then slowly cooled to room temperature.
The measurements were performed for nine different con-
centrations of each quadruplex in the concentration range
10
 5–10
 6 M using 10mm (300ml) quartz microcuvettes.
Absorbance versus temperature curves were obtained by
the UV melting method at 295nm (42–44) in the tempera-
ture range 5–95 C on a Beckman DU 800 spectrophotom-
eter equipped with a six-position microcell holder and a
thermoprogrammer. The reversibility of transitions was
ensured for all samples by measurement of heating and
cooling proﬁles (data not shown). Three different heating
rates (0.5, 0.3 and 0.2 C/min) were tested to avoid hyster-
esis phenomena. The rate of 0.2 C/min was selected
because here the melting and annealing curves were repro-
ducible and strictly superimposable. The lack of hysteresis
phenomena implied that the quadruplex dissociation–
association process was in a state of thermodynamic equi-
librium (42,43). Melting curves were analyzed and the
thermodynamic parameters determined by non-linear
curve ﬁtting with the program MeltWin 3.5 (45). Melting
temperatures calculated for 10
 4 M oligonucleotide con-
centration are marked by TM and melting points for any
other concentration of oligonucleotide by Tm.
CD spectra
CD spectra were recorded on a Jasco J-600A spectropo-
larimeter using 1ml quartz cuvettes with a 5mm path
length. The oligonucleotides were dissolved to 3.1mM
concentration in 10mM phosphate buffered saline
(138mM NaCl, 2.7mM KCl, 10mM Na2HPO4,
1.76mM KH2PO4), pH 7.4. All samples were renatured
by 2min at 100 C and slowly cooled to room temperature
before data collection. The measurements were done at
20 C in the 200–300nm wavelength range. The buffer
spectrum was subtracted from the sample spectra. The
spectra were smoothed in Microcal Origin 6.0 using a
Savitzky-Golay ﬁlter.
Thermal difference spectra
The measurements were performed on a Beckman DU 800
spectrophotometer equipped with a six-position microcell
holder and a thermoprogrammer using 10mm quartz
microcuvettes. The oligonucleotides were dissolved to
3.1mM concentration in a buffer containing 100mM
potassium chloride and 10mM sodium cacodylate, pH
7.0. Absorbance spectra were recorded at 13 C and 85 C
in the 220–320nm wavelength range. The scan speed was
1200nm/min with a data collection of 1pt/nm. Thermal
difference spectra were obtained by subtraction of the low
temperature absorbance spectra from the high tempera-
ture absorbance spectra with the Origin 6.0 program.
The differential spectra were normalized by dividing the
data by its maximum value (46).
Thrombin-aptamer afﬁnity analysis by surface plasmon
resonance
Real-time measurement of the interaction between
thrombin and TBA and all UNA-modiﬁed TBAs was
performed using a BIAcore 2000 system. Research grade
Table 1. Thermodynamic parameters of quadruplex formation with UNA (X)
a
Name Sequence
b  H  (kcal/mol)  S  (eu) G 
37 (kcal/mol) TM
c ( C) G 
37 (kcal/mol) TM
c ( C)
TBA GGTTGGTGTGGTTGG 36.6±0.4 116.1±1.3 –0.61±0.02 42.2 0 0
G1 GGTTGGTGTGGTTGG 30.9±1.8 102.1±5.7 +0.74±0.01 29.8 1.35  12.4
G2 GGTTGGTGTGGTTGG n.d. n.d. n.d. <20.0 n.d. n.d.
U3 GGUTGGTGTGGTTGG 39.4±0.4 124.4±1.1 –0.84±0.02 43.8  0.23 1.6
U4 GGTUGGTGTGGTTGG 29.0±2.2 94.2±7.0 +0.23±0.02 34.6 0.84  7.6
G5 GGTTGGTGTGGTTGG 41.6±1.3 141.1±4.3 +2.15±0.06 21.8 2.76  20.4
G6 GGTTGGTGTGGTTGG n.d. n.d. n.d. <20.0 n.d. n.d.
U7 GGTTGGUGTGGTTGG 38.6±1.1 121.0±3.8 –1.11±0.04 46.2  0.50 4.0
G8 GGTTGGTGTGGTTGG 31.1±0.9 101.4±3.0 +0.35±0.03 33.6 0.96  8.6
U9 GGTTGGTGUGGTTGG 32.7±2.4 106.9±7.7 +0.47±0.04 32.6 1.08  9.6
G10 GGTTGGTGTGGTTGG n.d. n.d. n.d. <20.0 n.d. n.d.
G11 GGTTGGTGTGGTTGG n.d. n.d. n.d. <20.0 n.d. n.d.
U12 GGTTGGTGTGGUTGG 35.9±0.62 113.4±2.0  0.76±0.01 43.7  0.15 1.5
U13 GGTTGGTGTGGTUGG 31.6±2.5 104.4±8.2 +0.80±0.06 29.4 1.41  12.8
G14 GGTTGGTGTGGTTGG n.d. n.d. n.d. <20.0 n.d. n.d.
G15 GGTTGGTGTGGTTGG 39.3±1.8 133.1±5.8 +2.05±0.05 21.6 2.66  20.6
1kcal=4.184kJ.
abuffer: 100mM KCl, 10mM sodium cacodylate, pH 7.0.
b50-biotinylated oligonucleotides.
ccalculated for 10
 4 M oligomer concentration.
n.d., not determined.
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buffer for immobilization and sample analysis was 10mM
phosphate buffered saline (138mM NaCl, 2.7mM KCl,
10mM Na2HPO4, 1.76mM KH2PO4, 0.05% Tween-20),
pH 7.4 at 25 C. Oligonucleotide immobilization was per-
formed by the streptavidin-biotin coupling method.
The ﬂow rate was set to 5ml/min, and the biotin TBA
and UNA-modiﬁed TBAs were injected at a concentration
of 1mM over the streptavidin surface (SA sensor chip) for
15min at 25 C. The unbound oligonucleotide was
removed by treatment with 50mM aqueous NaOH and
the chip was primed before use. Thrombin solutions were
sequentially injected over the sensor surface for 2min at
15ml/min and 2min dissociation time. For each oligo-
nucleotide, four concentrations of thrombin were
injected by serially diluting samples from 200 to 25nM
along with a bovine serum albumin (BSA) sample as a
non-speciﬁc target and a blank sample containing only
running buffer for referencing.After each run, the
surface was regenerated with 50mM aqueous NaOH for
20s at 15ml/min. The raw data were processed and
analyzed to determine the binding constant for each
oligonucleotide. To correct for refractive index changes
and instrument noise, the response data from the control
surface were subtracted from the responses obtained from
the reaction surface using biospeciﬁc interaction analysis
evaluation 4.1. The KD values were calculated by global
ﬁtting of the four concentrations of thrombin over a
constant density oligonucleotide surface. A 1:1 binding
mode with mass transfer ﬁtting was used to obtain the
kinetic data.
The effects of UNA modiﬁed TBA on thrombin time
The inhibitory effect of TBA and the UNA modiﬁed
variants on clotting time was measured by a thrombin
time assay. The time (in seconds) for clotting at 37 C
was measured on a STA-R EVOLUTION instrument
(Stago) after mixing the identical volumes of citrate
plasma and Trombin reagent (STA-THROMBIN 00611,
Diagnostica Stago). A pool of plasma from four healthy
individuals was used. The thrombin reagent was
pre-incubated with TBA or the TBA variants at 0.33mM
concentration for 5min before addition to plasma and
measurement of clotting time (= thrombin time).
The anti thrombin effect is the additional time for
clotting in presence of the aptamers relative to a reference
with water added.
RESULTS
In this study, all experiments are performed with aptamers
containing 50-biotin and a linker. This is required for the
surface plasmon resonance experiments and allowed us to
directly correlate data obtained from different types of
studies. From preliminary (not published) experiments
we know that 50-biotin decreases thermodynamic stability
and biological activity of the TBA in study herein but we
assume that the effect is the same for all the 50-biotinylated
TBA variants investigated.
Thermodynamic and spectroscopic features of UNA-
modiﬁed TBA variants
UNA monomers were introduced as single substitutions at
all possible positions of TBA resulting in 15 different TBA
variants. Melting curves for each variant provided the
thermodynamic parameters shown in Table 1. Only
three UNA-modiﬁed TBAs, namely U3, U7 and U12
(marked by underlined italic font to differentiate
between name of the aptamer and UNA monomer
position within an aptamer), together with unmodiﬁed
TBA, showed a negative value of Gibbs’ free energy
indicating formation of quadruplex structure at 37 C.
Moreover, these three modiﬁed variants display increased
thermodynamic stability relative to TBA (by 0.23, 0.50
and 0.15kcal/mol, respectively). Substitution of position
T7 by UNA-U was the most energetically favorable for
quadruplex formation. In contrast, modiﬁcation of any of
the guanosine monomers forming G-quartets resulted in
signiﬁcant destabilization of the quadruplex structure by
at least 1.35kcal/mol. Thus, UNA monomers only stabil-
ize the TBA quadruplex structure when placed in speciﬁc
positions of the loops. Plotting 1/Tm as a function of the
concentration of each of the 15 oligonucleotide variants
showed no concentration dependence of Tm (Figure 3).
CD spectra were recorded for TBA and all
UNA-modiﬁed TBAs to monitor the inﬂuence of UNA
on the overall structure (Figure 4). The majority of the
spectra for the UNA-modiﬁed TBAs show strongly
decreased intensity of the CD bands or even band loss
relative to the spectrum of the unmodiﬁed TBA.
However, the CD spectra of U3 and U7 show slightly
more intense bands than TBA with a high-amplitude
positive maximum near 293nm. Also the spectrum of
U12 shows a signiﬁcant band at  293nm, but its intensity
is lower than in the spectrum of TBA suggesting that it
originates from a less populated molecular conformation.
Thermal difference spectra (TDS) were recorded
(Figure 5) to support the results obtained from the CD
spectra. The spectra obtained divide the modiﬁed TBAs
into three groups. The ﬁrst group containing the U3, U7
and U12 variants presents a typical intramolecular TBA
quadruplex proﬁle. They have two positive maxima  240
and 273nm, and also one moderately intense peak
 260nm and one highly negative peak  295nm. The
second group constitutes G1 and the modiﬁed TBAs pos-
sessing a UNA monomer situated in the TGT or TT loops
(except the U3, U7 and U12 variants). No typical
quadruplex signature was observed for this group,
mainly due to disappearance of the negative peak
 260nm. The third group consists of TBAs modiﬁed in
any of the positions entangled in G-quartets formation,
except position G1. They show a complete loss of the
proﬁle characteristic for G-quadruplexes. Thus, all the
data obtained from the thermal difference spectra are con-
sistent with the conclusions from the CD spectra and the
thermodynamic studies.
Afﬁnity of UNA-modiﬁed TBAs to thrombin
To assay binding of the UNA-modiﬁed TBAs to thrombin
we used surface plasmon resonance (SPR) studies. For this
1158 Nucleic Acids Research, 2011,Vol.39, No. 3purpose all TBA variants contained a 50-biotin group with
a C6 spacer to facilitate binding to the surface of a
streptavidin-coated sensor chip. SPR analysis was used
to determine the kinetic constants at thrombin concentra-
tions ranging from 25 to 200nM. The kinetic proﬁle of the
unmodiﬁed TBA revealed a dissociation constant (KD)
value of 102.6nM (Table 2). U7 shows a small but signiﬁ-
cant improvement of afﬁnity (KD=78.2nM), while G1
and U9 show afﬁnities similar to the unmodiﬁed TBA.
In contrast, G8 displays a signiﬁcant loss of afﬁnity
(KD=916.3nM), while the rest of the modiﬁed TBAs
showed KD values from 154.7 to 425.1nM. No KD
values were measurable for G11, U13 and G14,
presumably due to lack of signiﬁcant afﬁnity towards
thrombin after incorporation of UNA in these positions.
The biological effect of the UNA-modiﬁed TBAs tested in
a thrombin time assay
To investigate whether the UNA-modiﬁed TBAs inhibit
the enzymatic activity of thrombin and to correlate the
biological effect with our chemical and kinetic data, a
selection of the modiﬁed TBAs was tested in a simple
thrombin time assay (Table 2). The variants were chosen
based mainly on their ability to form G-quadruplex
structure (CD, TDS) and therefore do not include
modiﬁcation of G-quartets positions with the only two
exceptions being G1 and G15. U7 showed an increased
inhibitory effect relative to the unmodiﬁed TBA, while
inhibition of coagulation by G1, U3, G8, U9 and U12
was  2-fold decreased, and U4, U13 and G15 showed
no inﬂuence on ﬁbrin-clot formation.
DISCUSSION
The inﬂuence of UNA monomers on thermodynamic
stability of the TBA quadruplex structure
The thermodynamic studies of the TBA variants revealed
signiﬁcant destabilization of quadruplexes when UNA
occupied any of the G-quartets forming positions
(Table 1). This is expected as UNA monomers are very
ﬂexible and parallels the effect of UNA monomers on
duplex thermodynamic stabilities (32–35). The magnitude
of destabilization hindered the determination of compre-
hensive thermodynamic data for the majority of these
variants. The thermodynamic parameters for G1, G5 and
G15 reveal quadruplex destabilization. The relatively
higher stability of the G1 and G15 variants is presumably
due to the terminal positioning of the UNA-G modiﬁca-
tion with a neighboring nucleobase only at one side.
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Nucleic Acids Research,2011, Vol.39, No. 3 1159In general, terminal nucleotide monomers are often
characterized by slightly weaker interactions than
internal monomers, and the magnitude of destabilization
caused by a modiﬁcation therefore should decrease when
shifting towards an oligonucleotide end (35,47).
Surprisingly, the UNA-G situated internally at position
G5 destabilizes the quadruplex structure only to a level
comparable to G15. Therefore, other differences than the
terminal positioning seem to contribute to the change of
the overall thermodynamic stability of the TBA variants.
The G1 shows a less favorable enthalpy change which
compensates the favorable increase of entropy and
results in an increase of G 
37. In contrast, the less
stable G5 and G15 display favorable enthalpy contribu-
tions accompanied by unfavorable entropic changes.
UNA modiﬁcations in positions U4, G8, U9 or U13 of
the quadruplex loops also signiﬁcantly decrease the
thermodynamic stability of the quadruplexes which
might be expected based on the reported NMR and
X-ray studies which have revealed that the G8 and T9
positions are situated in proximity to G6 and G15 of the
ﬁrst G-quartet, while T4 and T13 are close to guanines of
the ﬁrst or second G-quartet (17,19,48). Furthermore, the
O4 carbonyl group and the N3 imino proton of T4 and
T13 are involved in hydrogen bond formation (17,19,49).
The unfavorable effect of UNA placed in the G-quartets
might be explained by distortion of guanine stacking and
hydrogen bond interaction essential for quadruplex
folding, and the destabilization effects caused by UNA
observed for some speciﬁc positions in the loops might
by due to disturbance of interactions between the loop
and the quadruplex core or the U4:U13 hydrogen
bonding interaction.
The stabilization of quadruplex structure observed for
U3, U7 or U12 corresponds to  1.5- to 2-fold more
favorable equilibrium constant for quadruplex formation
relative to the TBA reference (Table 1). It has been
reported that substitution of all thymidines by
20-deoxyuridine monomers increases the thermodynamic
stability of TBA by 0.16kcal/mol per modiﬁcation on
average (26). UNA-U in position U12 thus stabilizes the
quadruplex structure to an extent comparable to a
20-deoxyuridine monomer, whereas the presence of a
UNA-U monomer in positions U3 and U7 is more favor-
able than a 20-deoxyuridine monomer for quadruplex
folding. Therefore, the observed stabilization is presum-
ably not only due to the absence of the methyl group in
position 5 of the thymine nucleobases but also the
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Figure 5. Representative high- (dotted line) and low-temperature (dashed line) absorbance thermal difference spectra (TDS, solid line) (a) TBA,
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G15. For single TDS proﬁles see ‘Supplementary Data’.
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enthalpies per G-quartet for TBA and U3, U7 and U12
revealed comparable values of  18.3,  19.7,  19.3 and
 18.0kcal/mol, respectively, corresponding to values
reported previously for single G-quartets (50). Finally,
the analysis of enthalpy-entropy contribution revealed a
favorable enthalpic change which is only partially
compensated by an unfavorable entropic change for U3
and U7, while the higher stability of U12 seems to have an
entropic origin.
The molecularity of folding can be determined by the
concentration dependence of Tm values. In general, the Tm
value of an unimolecular structural motif is concentration
independent, whereas an increase of sample concentration
results in enhanced Tm values if structures with higher
molecularity are formed (44). To verify an intramolecular
folding of the TBA variants, Tm as a function of
oligonucleotide concentration was studied and as
no linear increase was observed an intramolecular
folding mechanism for the studied structures was con-
ﬁrmed (Figure 3).
Structural features of the TBA variants
CD spectra can be used to distinguish between the differ-
ent quadruplex folding topologies, as parallel and antipar-
allel structures are characterized by different CD proﬁles
with high-amplitude band at 265 and 293nm, respectively
(27). The CD spectra for U3, U7 and U12 show a CD
proﬁle indicating antiparallel folding topology as for
TBA while G2, G5, G6, G10, G11, G14 and G15 show
no evidence for quadruplex formation.
It has been reported that the global shapes of TDS are
speciﬁc for a given RNA/DNA structure (46). This is in
accordance with our studies where three different TDS
patterns were registered for the TBA variants (Figure 5).
A TDS proﬁle with two maxima at 240 and 273nm and
two minima at 260 and 295nm that can be attributed to an
intramolecular quadruplex structure (46), a TDS proﬁle
with reduced intensity of the CD bands and irregular
TDS proﬁles with complete loss of a minimum at
260nm that most probably indicate more unstructured
states, and a TDS proﬁle that exhibit complete loss of
the typical quadruplex pattern. These results conﬁrm
those obtained from thermodynamic analysis and CD
spectra.
Thrombin-aptamer kinetics and biological activity
The kinetic binding study of the UNA-modiﬁed TBA
aptamers revealed that UNA modiﬁcations are allowed
in about half of the positions in TBA without largely
(>2-fold) changing the binding afﬁnity (positions G1,
U3, U4, U7, U9, U12 and G15). In contrast, UNA in
positions G11, U13 and G14 abolish or strongly inhibit
the interaction with thrombin. It has been suggested that
the TBA structure is retained after binding to thrombin
(48,51). We therefore can expect that changes in binding
constants are connected with changes of quadruplex
structure and also the thermodynamic stability of the
quadruplexes assuming higher stability for ideally
structured quadruplexes. According to structural studies,
G1 is involved in formation of the quadruplex core
and does not interact directly with the thrombin anion
exosite I (18–20). It was previously reported that substitu-
tion of G1 by isoguanosine leads to an improved binding
constant and retained thermodynamic stability (25).
The slightly lower KD value for G1 relative to TBA is
remarkable because according to the thermodynamic
and structural analysis (Table 1, Figures 4 and 5),
UNA-modiﬁcation at position G1 signiﬁcantly decreases
the thermodynamic stability and disturbs the overall
quadruplex folding. Apparently, increased ﬂexibility by
introduction of UNA monomer in this position is compat-
ible with favorable interactions between the aptamer and
thrombin. However, a similar behavior is observed for the
terminally modiﬁed G15 with a KD value slightly higher
than for the unmodiﬁed TBA.
U7 exhibits the lowest KD of all. According to X-ray
data of TBA bound to thrombin, T7 is buried in a
hydrophobic cluster in the ﬁbrinogen recognition site
(Figure 1b) (19,20). The increased afﬁnity may thus be
attributed to a favorable change of the orientation with
the T7 UNA-modiﬁed monomer leading to a better
quadruplex-protein complex ﬁt. On the contrary,
UNA-modiﬁcation of position G8 in the internal loop
signiﬁcantly reduces afﬁnity while variant U9 shows a
KD value similar to that of TBA. According to X-ray
structural data and by analogy with the observed
binding properties of U7, UNA modiﬁcation in positions
G8 and U9 could be favorable for interaction with
Table 2. Comparison of binding afﬁnity and biological effect of TBA
and UNA-modiﬁed TBA variants
Name Sequence
a KD (nM)
b T-time
c/
antithrombin
effect (s)
TBA GGTTGGTGTGGTTGG 102.6±5.1 28.8/9.9
G1 GGTTGGTGTGGTTGG 95.4±3.9 22.8/3.9
G2 GGTTGGTGTGGTTGG 298.1±5.7 n.d.
U3 GGUTGGTGTGGTTGG 160.4±4.9 24.0/5.1
U4 GGTUGGTGTGGTTGG 172.3±8.1 19.1/0.1
G5 GGTTGGTGTGGTTGG 425.1±17.7 n.d.
G6 GGTTGGTGTGGTTGG 287.2±12.3 n.d.
U7 GGTTGGUGTGGTTGG 78.2±4.9 32.6/13.7
G8 GGTTGGTGTGGTTGG 913.3±21.2 23.4/4.4
U9 GGTTGGTGUGGTTGG 110.3±4.1 24.4/5.4
G10 GGTTGGTGTGGTTGG 221.8±9.3 n.d.
G11 GGTTGGTGTGGTTGG n.d. n.d.
U12 GGTTGGTGTGGUTGG 190.3±8.2 23.2/4.2
U13 GGTTGGTGTGGTUGG n.d. 18.9/0.0
G14 GGTTGGTGTGGTTGG n.d. n.d.
G15 GGTTGGTGTGGTTGG 154.7±7.4 19.8/0.8
a50-biotinylated oligonucleotides.
bkinetic analysis of the afﬁnity interaction between immobilized TBA
variants and thrombin determined from kon/koff kinetic analysis.
c‘T-time’ is the time required for a clot formation in the plasma from a
blood sample.
‘Antithrombin effect’ is the T-time in the presence of an aptamer minus
the T-time in the absence of an aptamer; no oligo added resulted in
18.9 and 19.0s clotting times in two experimental sets and constitute
reference values in the antithrombin effect calculations. Non-biotin
conjugated TBA results in 34.4s clotting time.
n.d., not determined.
Nucleic Acids Research,2011, Vol.39, No. 3 1161thrombin due to structural changes. However, modiﬁca-
tion of each of the positions destabilizes a quadruplex
structure. The large difference in KD values between G8
and U9 might be explained by the observation from the
crystal structure that G8 stacks with the quadruplex core
whereas T9 is close to the T7 hydrophobic interaction site
(19). Making G8 ﬂexible with an UNA might reduce the
stacking ability while more ﬂexibility might ease the U9
positioning.
U3,U 4and U12 show similar, although slightly weaker
afﬁnity towards thrombin than unmodiﬁed TBA and by
reference to the X-ray studies, positions U3, U4 and U12
are not directly involved in the binding to the thrombin
anion exosite I. Accordingly, and conﬁrming our thermo-
dynamic and structural results, these UNA modiﬁcations
have only minor inﬂuence on the binding constants. UNA
modiﬁcation of positions G2, G5, G6, G10, G11 and G14
induces signiﬁcant loss of afﬁnity towards thrombin which
is likely due to the global disturbance of the quadruplex
structure as documented earlier.
Our binding data ﬁt the X-ray structure better than the
NMR based model regarding the TBA–thrombin inter-
actions. According to the NMR structure improved
thrombin binding should not be induced by the U7 modi-
ﬁcation as it was suggested that the central loop is not
directly involved in speciﬁc interactions with thrombin,
and the inhibitory effect rather is a consequence of
blocking thrombin anion exosite I by the two TT loops.
On the contrary, according to the X-ray structure, modi-
ﬁcation of the two TT loops should not signiﬁcantly
impact the binding constant anticipating that UNA
monomer induces only structural changes of local import-
ance, while introduction of UNA into the central loop
should provoke apparent changes in afﬁnity towards
thrombin, which correlate with our results.
Thrombin clotting time showed that several of the
studied TBA variants possess considerable biological
activity (Table 2), although most of them are less active
than unmodiﬁed TBA. We observe a clear correlation
between thermodynamics, kinetics and clotting time as
U3,U 7and U12 are stable quadruplexes and strong
thrombin binders displaying biological activity.
Similarly, the thermodynamically unstable U13 possess a
weak binding afﬁnity towards thrombin and is biologically
inactive. Less conclusive correlation was observed for the
unstable G1, U4, G8, U9 and G15 aptamers. U4 and G15
show no biological activity but considerable binding
afﬁnity, while G8 is biologically active but displays poor
thrombin binding. G1 and U9 seem to bind thrombin like
TBA and show biological activity even though the
thermodynamic stability is unfavorable. The less conclu-
sive correlation between thermodynamics, kinetics and
biological activity for some of our TBA variants might
be due to different conditions used in the experiments as
it has been found that not only potassium ions but also
molecular crowding and the presence of thrombin impact
quadruplex formation (52). Gratifyingly, the most
thermodynamically stable TBA variant U7 with high
binding afﬁnity also showed increased anticoagulant
activity relative to the unmodiﬁed TBA. In general, our
results are in accordance with a previously reported study
where only three TBA variants modiﬁed in positions
T3, T7, or T12 by an acyclic thymidine residue [1-N-
(3-hydroxy-2-hydroxymethyl-2-methylpropyl)thymidine]
showed higher thermal stability relative to the unmodiﬁed
aptamer (53). In the same study, variant T7 was the only
of all modiﬁcations characterized as more potent in blood
clotting than TBA.
CONCLUSIONS
The aptamers described in this article are the ﬁrst
examples of UNA-containing quadruplexes. In this
study we correlate thermodynamic studies of UNA-
modiﬁed TBA variants with structural aspects, thrombin
binding data and biological activity. UNA introduced at
positions U3, U7 or U12 make quadruplex folding more
energetically favorable than observed for the parent TBA.
Moreover, modiﬁcation at those positions preserves the
overall aptamer structure and retains the antiparallel,
intramolecular quadruplex topology seen for TBA. The
kinetic analyses revealed only three speciﬁc positions
(G11, U13 and G14) where incorporation of UNA
highly diminished or abolished thrombin binding.
Moreover, based on a thrombin clotting time assay one
aptamer, namely U7, was identiﬁed as more capable in
blood clotting than unmodiﬁed TBA. Our ﬁndings dem-
onstrate that UNA monomers are not only efﬁcient modu-
lators of quadruplex thermodynamic stability but also
change the binding afﬁnity and biological properties of
TBA in a position-depending manner. The results
provide a better understanding of the subtle features
involved in the interaction between TBA and thrombin
and facilitate the design of novel quadruplex-based
drugs with higher thermodynamic stability and improved
anticoagulant properties.
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